CDKN2B is critical for verapamil-mediated reversal of doxorubicin resistance in hepatocellular carcinoma

In this study, we explored the function and mechanism of CDKN2B genes in verapamil (VER)-induced reversal of resistance to doxorubicin (ADM) chemotherapy in hepatocellular carcinoma (HCC). We examined 4 HCC cell lines and found that the expression levels of CDKN2B genes correlated with the level of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Zhang, Tengyue, Ma, Kelong, Huang, Jin, Wang, Shitang, Liu, Yabei, Fan, Gaofei, Liu, Miao, Yang, Guangshan, Wang, Cheng, Fan, Pingsheng
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5746364/
https://ncbi.nlm.nih.gov/pubmed/29299129
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22123
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados